These data suggest that DSP is inactivated in lung cancer by an epigenetic mechanism, leading to an increased sensitivity to apoptosis by cancer therapy, acting as a suppressor of the function of tumor, possibly through inhibition of the signaling pathway Wnt/β-catenin in non-small cell lung tumors. The gene discussed is DSP; the disease is neoplasm.